This announcement states that the next cohort will be used in conjunction with an existing (SOC) and this "may" include existing Anti-PD-1 drugs, there are only 7 approved (that I could find) so take your pick on who we "may" be teaming up with in the next trial.
Also do some due diligence and check out the reviews, there are some really bad experiences with some of these monoclonal drugs, IMHO they will be scambling to get on board with our safety trial.
See below
https://www.drugs.com/comments/pembrolizumab/keytruda.html
Ann: PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting, page-36
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |